· Unmet medical needs exist for prostate cancer in China
· Inhibit directly: RAF/MEK/ERK
· Inhibit indirectly: block tumor angiogenesis
· Proprietary platform
· Unique pro-drug design targeted to specific organs and tumor types
Compared to products of similar category:
· ORR x2
· TTP x130%